IQVIA and Veeva Forge Robust Global Partnerships to Advance Clinical and Commercial Solutions
In a significant move for the life sciences sector, IQVIA and Veeva Systems have established a long-term partnership focused on optimizing clinical and commercial operations. Effective August 18, 2025, this collaboration aims to leverage their respective technologies and expertise to improve efficiency and effectiveness for their clients.
This partnership comes on the heels of the complete resolution of all previous legal disputes between the two companies, marking a new era of collaboration. Under the new agreements, customers can seamlessly integrate the software, data, and technology offered by both companies.
The partnership encompasses several key areas of operation:
1. Enhanced Data Access and Integration: Both companies have established third-party access agreements that allow for the utilization of data from IQVIA within Veeva’s systems, as well as vice versa. This includes integrating IQVIA data into Veeva’s Network, Nitro analytics, and AI functionalities, which will simplify data management and enhance analytical capabilities for customers.
2. Streamlined Clinical Processes: In terms of clinical operations, IQVIA has joined Veeva’s Clinical Data Partner Program, facilitating the execution of clinical trials via the Veeva Clinical Suite. This integration is expected to accelerate the management of clinical trials, enabling improved study designs and quicker database locks and data delivery.
3. Frictionless Customer Experience: Ari Bousbib, IQVIA’s CEO, stressed that the objective of these partnerships is to provide best-in-class solutions for their shared clients. By combining their expertise, these organizations aim to bring innovations to market more efficiently, enhancing patient access to critical treatments.
Peter Gassner, CEO of Veeva, expressed excitement about the future of this partnership and its potential to deliver significant value to clients. The leaders are committed to supporting a smooth integration of products and services between the two companies, indicating a proactive approach to meeting client needs in an evolving healthcare landscape.
IQVIA is recognized globally as a premier provider of clinical research services, operational insights, and healthcare intelligence tailored for the life sciences industry. Their innovative portfolio is powered by advanced analytics and AI technologies designed to enhance patient outcomes.
Veeva Systems, a leader in cloud software for the life sciences sector, is focused on innovation and product excellence. Supporting over 1,000 customers, from biopharmaceutical giants to emerging companies, Veeva aims to align the interests of its diverse stakeholders, including customers and employees.
The formation of this robust partnership signals a powerful collaborative step in the clinical and commercial arenas of the life sciences sector. With a shared vision for optimizing the development and commercialization of medical treatments, both IQVIA and Veeva are poised to impact various facets of healthcare delivery, improving outcomes for patients globally. This landmark agreement represents not just a resolution of past disputes, but a commitment to future success in a rapidly evolving industry landscape.
To learn more, visit Veeva and IQVIA for further details on their collaboration efforts.
This partnership comes on the heels of the complete resolution of all previous legal disputes between the two companies, marking a new era of collaboration. Under the new agreements, customers can seamlessly integrate the software, data, and technology offered by both companies.
Benefits of the Partnership
The partnership encompasses several key areas of operation:
1. Enhanced Data Access and Integration: Both companies have established third-party access agreements that allow for the utilization of data from IQVIA within Veeva’s systems, as well as vice versa. This includes integrating IQVIA data into Veeva’s Network, Nitro analytics, and AI functionalities, which will simplify data management and enhance analytical capabilities for customers.
2. Streamlined Clinical Processes: In terms of clinical operations, IQVIA has joined Veeva’s Clinical Data Partner Program, facilitating the execution of clinical trials via the Veeva Clinical Suite. This integration is expected to accelerate the management of clinical trials, enabling improved study designs and quicker database locks and data delivery.
3. Frictionless Customer Experience: Ari Bousbib, IQVIA’s CEO, stressed that the objective of these partnerships is to provide best-in-class solutions for their shared clients. By combining their expertise, these organizations aim to bring innovations to market more efficiently, enhancing patient access to critical treatments.
Leadership on the Horizon
Peter Gassner, CEO of Veeva, expressed excitement about the future of this partnership and its potential to deliver significant value to clients. The leaders are committed to supporting a smooth integration of products and services between the two companies, indicating a proactive approach to meeting client needs in an evolving healthcare landscape.
About the Companies
IQVIA is recognized globally as a premier provider of clinical research services, operational insights, and healthcare intelligence tailored for the life sciences industry. Their innovative portfolio is powered by advanced analytics and AI technologies designed to enhance patient outcomes.
Veeva Systems, a leader in cloud software for the life sciences sector, is focused on innovation and product excellence. Supporting over 1,000 customers, from biopharmaceutical giants to emerging companies, Veeva aims to align the interests of its diverse stakeholders, including customers and employees.
Conclusion
The formation of this robust partnership signals a powerful collaborative step in the clinical and commercial arenas of the life sciences sector. With a shared vision for optimizing the development and commercialization of medical treatments, both IQVIA and Veeva are poised to impact various facets of healthcare delivery, improving outcomes for patients globally. This landmark agreement represents not just a resolution of past disputes, but a commitment to future success in a rapidly evolving industry landscape.
To learn more, visit Veeva and IQVIA for further details on their collaboration efforts.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.